Stay updated on Dolutegravir Kinetics in Primary HIV: Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir Kinetics in Primary HIV: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir Kinetics in Primary HIV: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The record now presents details of the completed DOLUPRIM study, including its eligibility criteria, treatment and study design, outcomes, enrollment, and study dates. It also indicates that the study is no longer recruiting participants.
    Difference
    37%
    Check dated 2026-11-07T12:20:07.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2, while the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T12:58:16.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-24T13:50:37.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the study record page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T13:42:38.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:45:39.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The error-page markup and related navigation were removed, signaling the study record will render as a regular page instead of an access-denied response.
    Difference
    0.5%
    Check dated 2026-09-26T17:12:28.000Z thumbnail image

Stay in the know with updates to Dolutegravir Kinetics in Primary HIV: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir Kinetics in Primary HIV: Clinical Trial page.